(Rac)-Atomoxetine-d7 (hydrochloride)

(Rac)-Atomoxetine-d7 (hydrochloride)

• UNSPSC Description: (Rac)-Atomoxetine-d7 (hydrochloride) is a deuterium labeled (Rac)-Atomoxetine hydrochloride. (Rac)-Atomoxetine hydrochloride is a racemic form of Atomoxetine hydrochloride. Atomoxetine hydrochloride is a potent and selective noradrenalin re-uptake inhibitor (Ki values are 5 nM, 77 nM and 1451 nM for inhibition of radioligand binding to human NET, SERT and DAT respectively)[1].
• Target Antigen: Isotope-Labeled Compounds; Serotonin Transporter; Sodium Channel
• Type: Isotope-Labeled Compounds
• Related Pathways: Membrane Transporter/Ion Channel;Neuronal Signaling;Others
• Applications: Neuroscience-Neuromodulation
• Field of Research: Neurological Disease
• Solubility: 10 mM in DMSO
• Smiles: CNCCC(C1=CC=CC=C1)OC2=C(C([2H])=C([2H])C([2H])=C2[2H])C([2H])([2H])[2H].[H]Cl
• Molecular Weight: 298.86
• References & Citations: [1]Bymaster FP, Katner JS, Nelson DL et al. Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology. 2002 Nov;27(5):699-711.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported